tradingkey.logo

Myomo Inc

MYO
0.803USD
+0.030+3.88%
Close 02/06, 16:00ETQuotes delayed by 15 min
30.87MMarket Cap
LossP/E TTM

Myomo Inc

0.803
+0.030+3.88%

More Details of Myomo Inc Company

Myomo, Inc. is a wearable medical robotics company that offers improved arm and hand function for those suffering from neurological disorders and upper-limb paralysis. The Company develops and markets the MyoPro product line, which is a myoelectric-controlled upper limb brace, or orthosis. MyoPro is a powered upper-limb orthosis designed to support the arm and restore function to the weakened or paralyzed arms of certain patients suffering from CVA stroke, brachial plexus injury, traumatic brain or spinal cord injury or other neuromuscular disease or injury. MyoPro senses a patient’s own electromyography (EMG) signals through non-invasive sensors on the arm and can restore an individual’s ability to perform activities of daily living, including feeding themselves, carrying objects and doing household tasks. MyoPro’s control technology utilizes an advanced human-machine interface based on non-invasive, patented electromyography, or EMG, control technology.

Myomo Inc Info

Ticker SymbolMYO
Company nameMyomo Inc
IPO dateJun 12, 2017
CEOGudonis (Paul R)
Number of employees184
Security typeOrdinary Share
Fiscal year-endJun 12
Address137 Portland Street
CityBOSTON
Stock exchangeNASDAQ OMX – NASDAQ Basic Amex
CountryUnited States of America
Postal code02114
Phone16179969058
Websitehttps://myomo.com/
Ticker SymbolMYO
IPO dateJun 12, 2017
CEOGudonis (Paul R)

Company Executives of Myomo Inc

Name
Name/Position
Position
Shareholding
Change
Mr. Paul R. Gudonis
Mr. Paul R. Gudonis
Chairman of the Board, President, Chief Executive Officer
Chairman of the Board, President, Chief Executive Officer
1.26M
+11637.00%
Mr. Thomas F. (Tom) Kirk, Ph.D.
Mr. Thomas F. (Tom) Kirk, Ph.D.
Lead Independent Director
Lead Independent Director
481.86K
+7437.00%
Mr. David A. Henry
Mr. David A. Henry
Chief Financial Officer
Chief Financial Officer
436.63K
+8727.00%
Dr. Harry Kovelman, M.D.
Dr. Harry Kovelman, M.D.
Chief Medical Officer
Chief Medical Officer
140.62K
+44141.00%
Ms. Heather C. Getz, CPA
Ms. Heather C. Getz, CPA
Independent Director
Independent Director
41.75K
+29720.00%
Mr. Thomas A. Crowley, Jr.
Mr. Thomas A. Crowley, Jr.
Independent Director
Independent Director
--
--
Mr. Micah J. Mitchell
Mr. Micah J. Mitchell
Chief Commercial Officer
Chief Commercial Officer
--
--
Dr. Milton M. Morris, Ph.D.
Dr. Milton M. Morris, Ph.D.
Independent Director
Independent Director
--
--
Name
Name/Position
Position
Shareholding
Change
Mr. Paul R. Gudonis
Mr. Paul R. Gudonis
Chairman of the Board, President, Chief Executive Officer
Chairman of the Board, President, Chief Executive Officer
1.26M
+11637.00%
Mr. Thomas F. (Tom) Kirk, Ph.D.
Mr. Thomas F. (Tom) Kirk, Ph.D.
Lead Independent Director
Lead Independent Director
481.86K
+7437.00%
Mr. David A. Henry
Mr. David A. Henry
Chief Financial Officer
Chief Financial Officer
436.63K
+8727.00%
Dr. Harry Kovelman, M.D.
Dr. Harry Kovelman, M.D.
Chief Medical Officer
Chief Medical Officer
140.62K
+44141.00%
Ms. Heather C. Getz, CPA
Ms. Heather C. Getz, CPA
Independent Director
Independent Director
41.75K
+29720.00%
Mr. Thomas A. Crowley, Jr.
Mr. Thomas A. Crowley, Jr.
Independent Director
Independent Director
--
--

Revenue Breakdown

Currency: USDUpdated: Tue, Jan 6
Currency: USDUpdated: Tue, Jan 6
FY2025Q3
FY2025Q2
FY2025Q1
By BusinessUSD
Name
Revenue
Proportion
Direct to patient
7.32M
72.56%
Clinical/Medical providers
2.77M
27.44%
Relevant data have not been disclosed by the company yet.
By Business
By Region
By BusinessUSD
Name
Revenue
Proportion
Direct to patient
7.32M
72.56%
Clinical/Medical providers
2.77M
27.44%

Shareholding Stats

Updated: Sat, Feb 7
Updated: Sat, Feb 7
Shareholders
Shareholder Types
Shareholders
Shareholders
Proportion
Rosalind Advisors, Inc.
9.86%
Herr Investment Group LLC
7.40%
Triple Gate Capital, LP
7.35%
Horton Capital Management LLC
5.10%
The Vanguard Group, Inc.
4.05%
Other
66.23%
Shareholders
Shareholders
Proportion
Rosalind Advisors, Inc.
9.86%
Herr Investment Group LLC
7.40%
Triple Gate Capital, LP
7.35%
Horton Capital Management LLC
5.10%
The Vanguard Group, Inc.
4.05%
Other
66.23%
Shareholder Types
Shareholders
Proportion
Hedge Fund
28.04%
Investment Advisor
19.55%
Individual Investor
7.38%
Investment Advisor/Hedge Fund
6.33%
Research Firm
3.44%
Pension Fund
0.12%
Bank and Trust
0.08%
Other
35.06%

Institutional Shareholding

Updated: Thu, Jan 1
Updated: Thu, Jan 1
Reporting Period
No. of institutions
Shares Held
Proportion
Change
2025Q4
166
21.70M
56.46%
-4.40M
2025Q3
153
21.95M
58.07%
-1.84M
2025Q2
131
25.59M
71.13%
+1.42M
2025Q1
128
23.88M
66.62%
+977.96K
2024Q4
112
23.29M
69.71%
+5.81M
2024Q3
85
19.54M
71.85%
+1.13M
2024Q2
79
18.43M
69.76%
+448.58K
2024Q1
77
16.43M
64.97%
-1.27M
2023Q4
72
14.80M
62.04%
-346.58K
2023Q3
64
15.22M
79.76%
+6.49M
View more

Shareholder Activity

Name
Shares Held
Proportion
Change
Chg %
Date
Rosalind Advisors, Inc.
3.79M
9.86%
+195.00K
+5.42%
Sep 30, 2025
Herr Investment Group LLC
2.85M
7.4%
+1.20M
+72.93%
Jun 30, 2024
Triple Gate Capital, LP
2.83M
7.35%
--
--
Mar 31, 2025
Horton Capital Management LLC
1.96M
5.1%
+1.96M
--
Dec 24, 2025
The Vanguard Group, Inc.
1.49M
3.86%
-2.94K
-0.20%
Sep 30, 2025
BlackRock Institutional Trust Company, N.A.
1.50M
3.89%
-16.52K
-1.09%
Sep 30, 2025
Gudonis (Paul R)
1.25M
3.25%
-10.00K
-0.79%
Sep 09, 2025
Goldman Sachs & Company, Inc.
1.03M
2.69%
+666.49K
+181.56%
Sep 30, 2025
Geode Capital Management, L.L.C.
804.43K
2.09%
+135.15K
+20.19%
Sep 30, 2025
Renaissance Technologies LLC
712.09K
1.85%
+170.69K
+31.53%
Sep 30, 2025
View more

Related ETFs

Updated: Sat, Dec 6
Updated: Sat, Dec 6
Name
Proportion
iShares Micro-Cap ETF
0.01%
ProShares Hedge Replication ETF
0%
iShares Russell 2000 ETF
0%
iShares Russell 2000 Growth ETF
0%
Global X Russell 2000 ETF
0%
Proshares Ultra Russell 2000
0%
ProShares UltraPro Russell2000
0%
iShares Micro-Cap ETF
Proportion0.01%
ProShares Hedge Replication ETF
Proportion0%
iShares Russell 2000 ETF
Proportion0%
iShares Russell 2000 Growth ETF
Proportion0%
Global X Russell 2000 ETF
Proportion0%
Proshares Ultra Russell 2000
Proportion0%
ProShares UltraPro Russell2000
Proportion0%

Dividend

A total of 0.00 USD has been distributed in dividends over the past 5 years.
Date
Dividend
Record Date
Payment Date
Ex-dividend Date
No Data

Stock Splits

Date
Ex-dividend Date
Type
Ratio
No Data
Date
Ex-dividend Date
Type
Ratio
No Data
KeyAI